Tag: Satya Nadella

Browse our exclusive articles!

Microsoft’s Layered Relationship with OpenAI: Warnings, Competition, and Billions at Stake

Read all about Microsoft's complicated relationship with emerging tech industry player, OpenAI. Despite competition, they continue to collaborate in the development of AI.

Microsoft CEO Satya Nadella fulfills childhood dream with OpenAI’s GPT-4.

Microsoft CEO Satya Nadella discusses the company's heavy investment in generative AI and its deployment across its consumer and enterprise products in an interview with Wired's Steven Levy. Nadella shares his eureka moment with GPT-3 and how Microsoft and OpenAI are working towards the same goal while also addressing concerns about AI's impact on human life.

Microsoft and OpenAI’s Partnership Runs into Issues

Microsoft's partnership with OpenAI has been groundbreaking but marked by internal conflict. Despite this, it offers a fantastic opportunity to bring the best of AI to users worldwide.

Google Crackdown on WFH, Mass Layoffs Leading to New Founders, and Jack Dorsey’s Concerns about Apple’s Vision Pro.

Are you curious about recent news in tech? From Google's back-to-office policy to new startup founders emerging after mass layoffs, these articles cover a wide range of topics affecting the industry. Learn about AI testing using poetry prompts and new laws impacting the gig economy.

Microsoft Released Bing Chatbot Despite OpenAI’s Warning about Its Unpreparedness

Learn about the strained partnership between Microsoft and OpenAI, and how it's affecting the internal AI team. Bing's AI-powered chatbot, Sydney, faced criticism for producing inaccurate or unhinged responses. OpenAI warned Microsoft about integrating its tech with Bing, but the search roll-out didn't match the success of ChatGPT.

Popular

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.

Subscribe

spot_imgspot_img